80/100B160.420
USD
-2.88
(-1.76%)
Pre Open
Last updated: · Delayed 15 min
Fair value128.72Plus+25%103Price 160.42634
Q4 FY2026 · Earnings report
EPS estimate 2.23Revenue estimate 14.65B
Q4 FY2026 · Earnings report
EPS estimate 2.23Revenue estimate 14.65B
Novartis net income 1998–2026What is an income statement? The income statement shows a company's revenue, costs and profit over a quarter or a year, from sales at the top to net income at the bottom.
Novartis earned 1.20B USD in Q3 FY2026, the three months to 30 September 2026, down 69.4% on the same quarter a year before. Novartis's net income over the last twelve months was 10.03B USD, down 30.3% on the twelve months before. In fiscal year 2025 it earned 13.98B USD, up 17.1% on the year before.
Last updated 8 Nov 2026 · Next report 3 Feb 2027
Net income
Net income · -2.4% a year over 10 yearsNet margin
Growth
| Fiscal year | Period ending | Net income | Growth | Net margin | Revenue |
|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | 10.03B | -30.29% | 17.82% | 56.31B |
| FY2025 | 31 Dec 2025 | 13.98B | +17.11% | 25.51% | 54.81B |
| FY2024 | 31 Dec 2024 | 11.94B | -19.59% | 23.09% | 51.72B |
| FY2023 | 31 Dec 2023 | 14.85B | +113.52% | 31.83% | 46.66B |
| FY2022 | 31 Dec 2022 | 6.96B | -71.05% | 16.00% | 43.46B |
| FY2021 | 31 Dec 2021 | 24.02B | +197.58% | 54.63% | 43.97B |
| FY2020 | 31 Dec 2020 | 8.07B | -31.20% | 16.18% | 49.90B |
| FY2019 | 31 Dec 2019 | 11.73B | -6.97% | 24.10% | 48.68B |
| FY2018 | 31 Dec 2018 | 12.61B | +63.72% | 27.36% | 46.10B |
| FY2017 | 31 Dec 2017 | 7.70B | +14.76% | 17.75% | 43.40B |
| FY2016 | 31 Dec 2016 | 6.71B | -62.26% | 13.58% | 49.44B |
| FY2015 | 31 Dec 2015 | 17.78B | +74.17% | 35.29% | 50.39B |
| FY2014 | 31 Dec 2014 | 10.21B | +11.28% | 19.04% | 53.63B |
| FY2013 | 31 Dec 2013 | 9.18B | -1.02% | 17.40% | 52.72B |
| FY2012 | 31 Dec 2012 | 9.27B | +3.69% | 17.84% | 51.97B |
| FY2011 | 31 Dec 2011 | 8.94B | -8.72% | 15.06% | 59.38B |
| FY2010 | 31 Dec 2010 | 9.79B | +16.60% | 18.99% | 51.56B |
| FY2009 | 31 Dec 2009 | 8.40B | +2.50% | 18.62% | 45.10B |
| FY2008 | 31 Dec 2008 | 8.20B | -31.40% | 19.24% | 42.58B |
| FY2007 | 31 Dec 2007 | 11.95B | +66.49% | 30.67% | 38.95B |
| FY2006 | 31 Dec 2006 | 7.18B | +17.05% | 20.44% | 35.11B |
| FY2005 | 31 Dec 2005 | 6.13B | +14.26% | 20.60% | 29.75B |
| FY2004 | 31 Dec 2004 | 5.37B | +13.11% | 19.67% | 27.28B |
| FY2003 | 31 Dec 2003 | 4.74B | +0.38% | 19.03% | 24.93B |
| FY2002 | 31 Dec 2002 | 4.73B | +23.18% | 22.63% | 20.88B |
| FY2001 | 31 Dec 2001 | 3.84B | -14.13% | 20.45% | 18.76B |
| FY2000 | 31 Dec 2000 | 4.47B | +6.84% | 20.14% | 22.19B |
| FY1999 | 31 Dec 1999 | 4.18B | -4.28% | 20.51% | 20.39B |
| FY1998 | 31 Dec 1998 | 4.37B | — | 18.96% | 23.04B |
| Quarter | Period ending | Net income | Growth on a year before | Net margin | Revenue |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.20B | -69.40% | 8.00% | 15.03B |
| Q2 FY2026 | 30 Jun 2026 | 3.27B | -19.17% | 22.65% | 14.42B |
| Q1 FY2026 | 31 Mar 2026 | 3.16B | -12.48% | 23.34% | 13.52B |
| Q4 FY2025 | 31 Dec 2025 | 2.41B | -14.52% | 18.06% | 13.33B |
| Q3 FY2025 | 29 Sept 2025 | 3.93B | +23.17% | 27.36% | 14.36B |
| Q2 FY2025 | 30 Jun 2025 | 4.04B | +24.49% | 27.24% | 14.84B |
| Q1 FY2025 | 31 Mar 2025 | 3.61B | +34.15% | 26.48% | 13.62B |
| Q4 FY2024 | 31 Dec 2024 | 2.82B | -66.77% | 20.78% | 13.56B |
| Q3 FY2024 | 30 Sept 2024 | 3.19B | +81.09% | 24.21% | 13.17B |
| Q2 FY2024 | 30 Jun 2024 | 3.25B | +40.16% | 25.22% | 12.87B |
| Q1 FY2024 | 31 Mar 2024 | 2.69B | +17.23% | 22.18% | 12.12B |
| Q4 FY2023 | 31 Dec 2023 | 8.48B | +478.44% | 72.01% | 11.78B |
| Q3 FY2023 | 30 Sept 2023 | 1.76B | +11.95% | 14.56% | 12.09B |
| Q2 FY2023 | 30 Jun 2023 | 2.32B | +36.72% | 19.72% | 11.75B |
| Q1 FY2023 | 31 Mar 2023 | 2.29B | +3.20% | 20.76% | 11.05B |
| Q4 FY2022 | 31 Dec 2022 | 1.47B | -91.01% | 11.20% | 13.09B |
| Q3 FY2022 | 30 Sept 2022 | 1.57B | -42.97% | 14.59% | 10.78B |
| Q2 FY2022 | 30 Jun 2022 | 1.69B | -41.51% | 12.95% | 13.09B |
| Q1 FY2022 | 31 Mar 2022 | 2.22B | +7.92% | 17.34% | 12.81B |
| Q4 FY2021 | 31 Dec 2021 | 16.31B | +678.80% | 120.60% | 13.52B |
| Q3 FY2021 | 30 Sept 2021 | 2.76B | +42.53% | 20.63% | 13.37B |
| Q2 FY2021 | 30 Jun 2021 | 2.90B | +55.12% | 21.78% | 13.29B |
| Q1 FY2021 | 31 Mar 2021 | 2.06B | -5.38% | 16.22% | 12.69B |
| Q4 FY2020 | 31 Dec 2020 | 2.09B | +86.13% | 16.07% | 13.03B |
| Q3 FY2020 | 30 Sept 2020 | 1.94B | -5.24% | 15.43% | 12.54B |
| Q2 FY2020 | 30 Jun 2020 | 1.87B | -72.54% | 16.06% | 11.62B |
| Q1 FY2020 | 31 Mar 2020 | 2.18B | +23.22% | 17.12% | 12.71B |
| Q4 FY2019 | 31 Dec 2019 | 1.13B | -5.86% | 8.85% | 12.72B |
| Q3 FY2019 | 30 Sept 2019 | 2.04B | +25.82% | 16.36% | 12.48B |
| Q2 FY2019 | 30 Jun 2019 | 6.80B | -12.47% | 56.55% | 12.02B |
| Q1 FY2019 | 31 Mar 2019 | 1.77B | -12.79% | 15.42% | 11.46B |
| Q4 FY2018 | 31 Dec 2018 | 1.20B | -39.52% | 8.75% | 13.66B |
| Q3 FY2018 | 30 Sept 2018 | 1.62B | -22.01% | 14.25% | 11.39B |
| Q2 FY2018 | 30 Jun 2018 | 7.77B | +292.32% | 66.66% | 11.65B |
| Q1 FY2018 | 31 Mar 2018 | 2.03B | +21.55% | 18.14% | 11.16B |
| Q4 FY2017 | 31 Dec 2017 | 1.98B | +106.48% | 15.01% | 13.16B |
| Q3 FY2017 | 30 Sept 2017 | 2.08B | +7.27% | 16.40% | 12.69B |
| Q2 FY2017 | 30 Jun 2017 | 1.98B | +9.76% | 15.85% | 12.49B |
| Q1 FY2017 | 31 Mar 2017 | 1.67B | -17.16% | 14.14% | 11.79B |
| Q4 FY2016 | 31 Dec 2016 | 957.00M | -9.20% | 7.59% | 12.61B |
| Q3 FY2016 | 30 Sept 2016 | 1.94B | +2.75% | 15.72% | 12.34B |
| Q2 FY2016 | 30 Jun 2016 | 1.80B | -1.74% | 14.23% | 12.68B |
| Q1 FY2016 | 31 Mar 2016 | 2.01B | -84.54% | 17.03% | 11.81B |
| Q4 FY2015 | 31 Dec 2015 | 1.05B | -29.31% | 8.23% | 12.80B |
| Q3 FY2015 | 30 Sept 2015 | 1.89B | -41.42% | 15.12% | 12.49B |
| Q2 FY2015 | 30 Jun 2015 | 1.84B | -28.14% | 14.24% | 12.90B |
| Q1 FY2015 | 31 Mar 2015 | 13.01B | +342.20% | 106.58% | 12.20B |
| Q4 FY2014 | 31 Dec 2014 | 1.49B | -26.52% | 11.17% | 13.35B |
| Q3 FY2014 | 30 Sept 2014 | 3.22B | +44.40% | 24.23% | 13.30B |
| Q2 FY2014 | 30 Jun 2014 | 2.56B | +1.55% | 18.32% | 13.95B |
| Q1 FY2014 | 31 Mar 2014 | 2.94B | +22.64% | 22.57% | 13.03B |
| Q4 FY2013 | 31 Dec 2013 | 2.03B | -0.78% | 13.21% | 15.36B |
| Q3 FY2013 | 30 Sept 2013 | 2.23B | -6.61% | 17.29% | 12.91B |
| Q2 FY2013 | 30 Jun 2013 | 2.52B | -4.98% | 18.95% | 13.28B |
| Q1 FY2013 | 31 Mar 2013 | 2.40B | +6.72% | 16.88% | 14.21B |
| Q4 FY2012 | 31 Dec 2012 | 2.05B | +74.04% | 13.57% | 15.07B |
| Q3 FY2012 | 30 Sept 2012 | 2.39B | -3.00% | 17.02% | 14.04B |
| Q2 FY2012 | 30 Jun 2012 | 2.65B | -2.07% | 18.21% | 14.54B |
| Q1 FY2012 | 31 Mar 2012 | 2.25B | -18.88% | 16.15% | 13.91B |
| Q4 FY2011 | 31 Dec 2011 | 1.18B | -45.83% | 7.84% | 15.00B |
| Q3 FY2011 | 30 Sept 2011 | 2.46B | +8.31% | 16.39% | 15.03B |
| Q2 FY2011 | 30 Jun 2011 | 2.70B | +11.87% | 17.88% | 15.12B |
| Q1 FY2011 | 31 Mar 2011 | 2.77B | -5.56% | 19.48% | 14.22B |
| Q4 FY2010 | 31 Dec 2010 | 2.17B | -5.90% | 15.00% | 14.46B |
| Q3 FY2010 | 30 Sept 2010 | 2.28B | +8.44% | 17.75% | 12.82B |
| Q2 FY2010 | 30 Jun 2010 | 2.42B | +18.77% | 20.28% | 11.92B |
| Q1 FY2010 | 31 Mar 2010 | 2.93B | +49.49% | 23.74% | 12.36B |
| Q4 FY2009 | 31 Dec 2009 | 2.31B | +49.77% | 17.54% | 13.15B |
| Q3 FY2009 | 30 Sept 2009 | 2.10B | +0.38% | 18.58% | 11.29B |
| Q2 FY2009 | 30 Jun 2009 | 2.04B | -9.52% | 18.94% | 10.74B |
| Q1 FY2009 | 31 Mar 2009 | 1.96B | -15.32% | 19.77% | 9.93B |
| Q4 FY2008 | 31 Dec 2008 | 1.54B | +70.24% | 14.87% | 10.35B |
| Q3 FY2008 | 30 Sept 2008 | 2.09B | -69.56% | 18.95% | 11.03B |
| Q2 FY2008 | 30 Jun 2008 | 2.25B | +12.00% | 20.46% | 10.99B |
| Q1 FY2008 | 31 Mar 2008 | 2.32B | +6.82% | 22.68% | 10.22B |
| Q4 FY2007 | 31 Dec 2007 | 904.00M | -45.34% | 8.89% | 10.17B |
| Q3 FY2007 | 30 Sept 2007 | 6.87B | +267.70% | 69.92% | 9.82B |
| Q2 FY2007 | 30 Jun 2007 | 2.01B | +17.63% | 21.36% | 9.40B |
| Q1 FY2007 | 31 Mar 2007 | 2.17B | +11.40% | 23.14% | 9.37B |
| Q4 FY2006 | 31 Dec 2006 | 1.65B | +22.52% | 17.75% | 9.32B |
| Q3 FY2006 | 30 Sept 2006 | 1.87B | +12.54% | 20.69% | 9.02B |
| Q2 FY2006 | 30 Jun 2006 | 1.71B | +3.71% | 20.06% | 8.51B |
| Q1 FY2006 | 31 Mar 2006 | 1.95B | +31.47% | 23.89% | 8.15B |
| Q4 FY2005 | 31 Dec 2005 | 1.35B | -2.03% | 15.42% | 8.75B |
| Q3 FY2005 | 30 Sept 2005 | 1.66B | +7.24% | 19.54% | 8.49B |
| Q2 FY2005 | 30 Jun 2005 | 1.65B | +6.26% | 20.91% | 7.87B |
| Q1 FY2005 | 31 Mar 2005 | 1.48B | +14.54% | 20.17% | 7.34B |
| Q4 FY2004 | 31 Dec 2004 | 1.38B | +1.32% | 18.18% | 7.58B |
| Q3 FY2004 | 30 Sept 2004 | 1.55B | +21.14% | 21.92% | 7.06B |
| Q2 FY2004 | 30 Jun 2004 | 1.55B | +17.71% | 22.21% | 6.97B |
| Q1 FY2004 | 31 Mar 2004 | 1.29B | +21.64% | 19.48% | 6.64B |
| Q4 FY2003 | 31 Dec 2003 | 1.36B | -18.95% | 20.21% | 6.73B |
| Q3 FY2003 | 30 Sept 2003 | 1.28B | +14.94% | 20.56% | 6.21B |
| Q2 FY2003 | 30 Jun 2003 | 1.32B | -5.46% | 21.22% | 6.20B |
| Q1 FY2003 | 31 Mar 2003 | 1.06B | -2.48% | 18.58% | 5.72B |
| Q4 FY2002 | 31 Dec 2002 | 1.68B | +62.60% | 21.50% | 7.81B |
| Q3 FY2002 | 30 Sept 2002 | 1.11B | -1.51% | 21.96% | 5.06B |
| Q2 FY2002 | 30 Jun 2002 | 1.39B | +33.97% | 24.87% | 5.60B |
| Q1 FY2002 | 31 Mar 2002 | 1.09B | +1.77% | 22.44% | 4.86B |
| Q4 FY2001 | 31 Dec 2001 | 1.03B | -5.49% | 20.09% | 5.14B |
| Q3 FY2001 | 30 Sept 2001 | 1.13B | +28.77% | 20.23% | 5.58B |
| Q2 FY2001 | 30 Jun 2001 | 1.04B | -18.95% | 24.10% | 4.31B |
| Q1 FY2001 | 31 Mar 2001 | 1.07B | -14.86% | 24.12% | 4.44B |
| Q4 FY2000 | 31 Dec 2000 | 1.09B | — | 18.32% | 5.96B |
| Q3 FY2000 | 30 Sept 2000 | 876.00M | — | 17.95% | 4.88B |
| Q2 FY2000 | 30 Jun 2000 | 1.28B | — | 29.97% | 4.28B |
| Q1 FY2000 | 31 Mar 2000 | 1.26B | — | 22.08% | 5.70B |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Novartis's profit
Source: Financial Modeling Prep